Clinical Trial Update: Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of a monoclonal antibody therapy in combination with a colony-stimulating factor for metastatic colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Colony Stimulating Factor
• Monoclonal antibody therapy

Snippet

Sponsor: James Ahlgren | Conditions: Colorectal Cancer | Phase 2 | Status: WITHDRAWN